153 related articles for article (PubMed ID: 25402286)
1. Risk factors for vancomycin nephrotoxicity: still a matter of debate*.
Costa e Silva VT; Marçal LJ; Burdmann EA
Crit Care Med; 2014 Dec; 42(12):2635-6. PubMed ID: 25402286
[No Abstract] [Full Text] [Related]
2. Vancomycin-associated nephrotoxicity: unintentional consequences of a loading dose?
Flannery AH; Bachmeier H
Crit Care Med; 2015 May; 43(5):e154. PubMed ID: 25876127
[No Abstract] [Full Text] [Related]
3. The authors reply.
Hanrahan TP; Harlow G; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
Crit Care Med; 2015 May; 43(5):e154-5. PubMed ID: 25876128
[No Abstract] [Full Text] [Related]
4. The Area Under the Concentration-Time Curve Is a Better Estimate for Vancomycin Exposure Than Trough Levels.
van Vessem DJ; Juffermans NP; Bouman CS; van Hest RM
Crit Care Med; 2015 Sep; 43(9):e401. PubMed ID: 26274735
[No Abstract] [Full Text] [Related]
5. The Nephrotoxicity of Vancomycin.
Filippone EJ; Kraft WK; Farber JL
Clin Pharmacol Ther; 2017 Sep; 102(3):459-469. PubMed ID: 28474732
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.
Hanrahan TP; Harlow G; Hutchinson J; Dulhunty JM; Lipman J; Whitehouse T; Roberts JA
Crit Care Med; 2014 Dec; 42(12):2527-36. PubMed ID: 25083977
[TBL] [Abstract][Full Text] [Related]
7. [Vancomycin nephrotoxicity: Frequency and mechanistic aspects].
Luque Y; Mesnard L
Nephrol Ther; 2018 Apr; 14 Suppl 1():S133-S138. PubMed ID: 29606259
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
Kollef MH; Juang P; Micek ST
Clin Infect Dis; 2020 Mar; 70(7):1520-1521. PubMed ID: 31297504
[No Abstract] [Full Text] [Related]
9. Vancomycin-induced nephrotoxicity.
Gelfand MS; Cleveland KO
Antimicrob Agents Chemother; 2013 May; 57(5):2435. PubMed ID: 23580581
[No Abstract] [Full Text] [Related]
10. Reply to "Vancomycin-induced nephrotoxicity".
van Hal SJ; Paterson DL; Lodise TP
Antimicrob Agents Chemother; 2013 May; 57(5):2436. PubMed ID: 23580582
[No Abstract] [Full Text] [Related]
11. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
[TBL] [Abstract][Full Text] [Related]
12. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates.
Constance JE; Balch AH; Stockmann C; Linakis MW; Korgenski EK; Roberts JK; Ward RM; Sherwin CM; Spigarelli MG
Arch Dis Child Fetal Neonatal Ed; 2016 May; 101(3):F236-43. PubMed ID: 26400103
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
McKamy S; Hernandez E; Jahng M; Moriwaki T; Deveikis A; Le J
J Pediatr; 2011 Mar; 158(3):422-6. PubMed ID: 20888013
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
Rostas SE; Kubiak DW; Calderwood MS
Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Burgess LD; Drew RH
Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury in a renal transplant recipient due to concomitant use of vancomycin and foscarnet.
Kwan LP; Mok MM; Choy BY; Chan TM
Nephrology (Carlton); 2017 Oct; 22(10):821-822. PubMed ID: 28921753
[No Abstract] [Full Text] [Related]
18. Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT).
Carreno JJ; Kenney RM; Divine G; Vazquez JA; Davis SL
Ann Pharmacother; 2017 Mar; 51(3):185-193. PubMed ID: 27838680
[TBL] [Abstract][Full Text] [Related]
19. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
20. Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.
O'Donnell JN; Ghossein C; Rhodes NJ; Peng J; Lertharakul T; Pham CK; Scheetz MH
J Infect Chemother; 2017 May; 23(5):326-332. PubMed ID: 28109741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
